MARKET

CERT

CERT

Certara, Inc.
NASDAQ
10.51
+0.78
+8.02%
After Hours: 12.94 +2.43 +23.12% 19:59 04/10 EDT
OPEN
9.49
PREV CLOSE
9.73
HIGH
10.61
LOW
8.72
VOLUME
3.71M
TURNOVER
--
52 WEEK HIGH
19.18
52 WEEK LOW
8.64
MARKET CAP
1.69B
P/E (TTM)
-139.9467
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-Certara jumps as FDA moves to replace animal testing
Reuters · 3h ago
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements
Benzinga · 4h ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 4h ago
Certara Is Maintained at Equal-Weight by Barclays
Dow Jones · 11h ago
Certara Price Target Cut to $11.00/Share From $13.00 by Barclays
Dow Jones · 11h ago
Barclays Maintains Equal-Weight on Certara, Lowers Price Target to $11
Benzinga · 11h ago
CERTARA <CERT.O>: BARCLAYS CUTS TARGET PRICE TO $11 FROM $13
Reuters · 14h ago
Certara price target lowered to $11 from $13 at Barclays
TipRanks · 15h ago
More
About CERT
More
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.
Recently
Symbol
Price
%Change

Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERT stock methods without spending real money on the virtual paper trading platform.